Sensitivity to censored‐at‐random assumption in the analysis of time‐to‐event endpoints

Over the past years, significant progress has been made in developing statistically rigorous methods to implement clinically interpretable sensitivity analyses for assumptions about the missingness mechanism in clinical trials for continuous and (to a lesser extent) for binary or categorical endpoints. Studies with time-to-event outcomes have received much less attention. However, such studies can be similarly challenged with respect to the robustness and integrity of primary analysis conclusions when a substantial number of subjects withdraw from treatment prematurely prior to experiencing an event of interest. We discuss how the methods that are widely used for primary analyses of time-to-event outcomes could be extended in a clinically meaningful and interpretable way to stress-test the assumption of ignorable censoring. We focus on a 'tipping point' approach, the objective of which is to postulate sensitivity parameters with a clear clinical interpretation and to identify a setting of these parameters unfavorable enough towards the experimental treatment to nullify a conclusion that was favorable to that treatment. Robustness of primary analysis results can then be assessed based on clinical plausibility of the scenario represented by the tipping point. We study several approaches for conducting such analyses based on multiple imputation using parametric, semi-parametric, and non-parametric imputation models and evaluate their operating characteristics via simulation. We argue that these methods are valuable tools for sensitivity analyses of time-to-event data and conclude that the method based on piecewise exponential imputation model of survival has some advantages over other methods studied here. Copyright © 2016 John Wiley & Sons, Ltd.

[1]  Søren Feodor Nielsen,et al.  1. Statistical Analysis with Missing Data (2nd edn). Roderick J. Little and Donald B. Rubin, John Wiley & Sons, New York, 2002. No. of pages: xv+381. ISBN: 0‐471‐18386‐5 , 2004 .

[2]  John S. Preisser,et al.  Sensitivity Analysis for Withdrawals in Grouped Time-to-Event Data , 2014 .

[3]  Donald B. Rubin,et al.  Multiple imputation in mixture models for nonignorable nonresponse with follow-ups , 1993 .

[4]  Haibo Zhou,et al.  A Multiple Imputation Method for Sensitivity Analyses of Time-to-Event Data with Possibly Informative Censoring , 2014, Journal of biopharmaceutical statistics.

[5]  Walter R. Gilks,et al.  Adaptive rejection metropolis sampling , 1995 .

[6]  P. Mock,et al.  A comparison of two simple hazard ratio estimators based on the logrank test. , 1991, Statistics in medicine.

[7]  D. Scharfstein,et al.  Survival curve estimation for informatively coarsened discrete event‐time data , 2007, Statistics in medicine.

[8]  Bohdana Ratitch,et al.  Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models , 2013, Pharmaceutical statistics.

[9]  D. Hill,et al.  Competing hazards with shared unmeasured risk factors. , 1993, Sociological methodology.

[10]  Trivellore E Raghunathan,et al.  A Bayesian model for time-to-event data with informative censoring. , 2012, Biostatistics.

[11]  Susan Murray,et al.  Survival estimation and testing via multiple imputation , 2002 .

[12]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[13]  Xiao-Li Meng,et al.  Multiple-Imputation Inferences with Uncongenial Sources of Input , 1994 .

[14]  E. B. Wilson,et al.  The Distribution of Chi-Square. , 1931, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Michael G. Kenward,et al.  Multiple Imputation and its Application , 2013 .

[16]  Stef van Buuren,et al.  Flexible Imputation of Missing Data , 2012 .

[17]  James R Carpenter,et al.  Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation , 2013, Journal of biopharmaceutical statistics.

[18]  D Scharfstein,et al.  Inference in Randomized Studies with Informative Censoring and Discrete Time‐to‐Event Endpoints , 2001, Biometrics.

[19]  S. Hammer,et al.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. , 1996, The New England journal of medicine.

[20]  James M. Robins,et al.  Estimation of the failure time distribution in the presence of informative censoring , 2002 .

[21]  R Little,et al.  Intent-to-treat analysis for longitudinal studies with drop-outs. , 1996, Biometrics.

[22]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[23]  M. Friedman Piecewise Exponential Models for Survival Data with Covariates , 1982 .

[24]  Geert Molenberghs,et al.  Missing Data in Clinical Studies , 2007 .

[25]  D.,et al.  Regression Models and Life-Tables , 2022 .

[26]  Geert Molenberghs,et al.  Strategies to fit pattern-mixture models. , 2002, Biostatistics.

[27]  D. Rubin Multiple Imputation After 18+ Years , 1996 .

[28]  Xu Yan,et al.  Missing Data Handling Methods in Medical Device Clinical Trials , 2009, Journal of biopharmaceutical statistics.

[29]  Michael G. Kenward,et al.  Multiple Imputation and its Application: Carpenter/Multiple Imputation and its Application , 2013 .

[30]  Michael J. Daniels,et al.  Missing data in longitudinal studies , 2008 .

[31]  M. N. Goria ON THE FOURTH ROOT TRANSFORMATION OF CHI-SQUARE , 1992 .

[32]  A. Dreher Modeling Survival Data Extending The Cox Model , 2016 .

[33]  Andrea Rotnitzky,et al.  Analysis of failure time data under competing censoring mechanisms , 2007 .

[34]  Harvey Goldstein,et al.  A general multilevel multistate competing risks model for event history data, with an application to a study of contraceptive use dynamics , 2004 .

[35]  Roger A. Sugden,et al.  Multiple Imputation for Nonresponse in Surveys , 1988 .

[36]  D. Rubin INFERENCE AND MISSING DATA , 1975 .

[37]  Fiona Steele,et al.  The determinants of the duration of contraceptive use in China: A multilevel multinomial discrete-hazards mdeling approach , 1996, Demography.

[38]  D. Rubin,et al.  Ignorability and Coarse Data , 1991 .

[39]  D. Heitjan,et al.  Nonignorable censoring in randomized clinical trials , 2005, Clinical trials.